2484. Telehealth for Substance Use Disorders: A Rapid Review for the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Substance Use Disorders.
作者: Stacey Uhl.;Aaron Bloschichak.;Amber Moran.;Kristina McShea.;Megan S Nunemaker.;James R McKay.;Kristen E D'Anci.
来源: Ann Intern Med. 2022年175卷5期691-700页
Approximately 20.4 million Americans met criteria for a substance use disorder (SUD) in 2019; however, only about 12.2% of persons with an SUD receive specialty care. Telehealth offers alternatives to traditional forms of substance use treatment.
2487. The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
作者: Christopher Perry.;Joseph Liberto.;Charles Milliken.;Jennifer Burden.;Hildi Hagedorn.;Timothy Atkinson.;James R McKay.;Larissa Mooney.;James Sall.;Comilla Sasson.;Andrew Saxon.;Christopher Spevak.;Adam J Gordon.; .
来源: Ann Intern Med. 2022年175卷5期720-731页
In August 2021, leadership within the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the management of substance use disorders (SUDs). This synopsis summarizes key recommendations.
2488. Risk for Acute Myocardial Infarction After Ophthalmologic Procedures.
作者: Abhijit Sen.;Katalin Gémes.;Gustav Stålhammar.;Christer Svensen.;Per Tornvall.;Magnus Jonsson.;Torunn Varmdal.;Birger Henning Endreseth.;Imre Janszky.;Jette Möller.
来源: Ann Intern Med. 2022年175卷5期628-633页
Preoperative cardiovascular evaluations are frequently done before ambulatory ophthalmologic procedures. However, whether these procedures can trigger an acute myocardial infarction (AMI) is unknown.
2490. Risk for Shoulder Conditions After Vaccination: A Population-Based Study Using Real-World Data.
作者: Chengyi Zheng.;Jonathan Duffy.;In-Lu Amy Liu.;Lina S Sy.;Wansu Chen.;Lei Qian.;Ronald A Navarro.;Denison S Ryan.;Sunhea S Kim.;Cheryl Mercado.;Steven J Jacobsen.
来源: Ann Intern Med. 2022年175卷5期634-643页
Although shoulder conditions have been reported as an adverse event after intramuscular vaccination in the deltoid muscle, epidemiologic data on shoulder conditions after vaccination are limited.
|